Table 1

Patients with Graves’ orbitopathy, diabetes mellitus, and dysthyroid optic neuropathy (n=5)

Patient (age in years)SexDMRetinopathyVA before DON treatmentDON treatmentVA after treatmentComment
1 (60)FIDDM0.6 0.6steroids orally two wall orbital decompression0.6 0.6
2 (66)FNIDDM0.6 0.6two wall orbital decompression steroids iv0.5 0.8
3 (65)FIDDM0.1 0.4three wall orbital decompression0.5 0.4
4 (60)FIDDMbackground retinopathy, panretinal photocoagulation scars0.016 0.25steroids iv two wall orbital decompression0.25 0.25
5 (65)MNIDDM0.5 0.6steroids iv0.6 1.0also myasthenia gravis
  • DM=diabetes mellitus; IDDM=insulin dependent diabetes mellitus; NIDDM=non-insulin dependent diabetes mellitus; VA=visual acuity; DON=dysthyroid optic neuropathy.